Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Weil Cornell Medical Center, New York

New York Medical College, Division of Oncology, Valhalla

North Shore University Hospital, Manhasset

University of Pittsburg Cancer Center, Pittsburgh

Blumenthal Cancer Center/Mecklenburg Medical Group, Charlotte

Blood and Marrow Transplant Group of Georgia, Atlanta

Shands Jacksonville Medical Center, Jacksonville

H Lee Moffitt Cancer Center and Research Institute, Tampa

Jewish Hospital, Cincinnati

St.Francis Hospital, Beech Grove

Froedlert Hospital/Medical College of Wisconsin, Milwaukee

Robert H.Lurie Comprehensive Cancer Center, Chicago

MD Anderson Cancer Center, Houston

Cancer Therapy and Research Center at the University of Texas, San Antonio

Joe Arrington Cancer Center, Lubbock

Texas Tech University Health Sciences Center, Lubbock

University of Colorado Cancer Center, Aurora

Cedars Sinai Medical Center, Los Angeles

University of California Medical Center, San Francisco

UC Davis Cancer Center, Sacramento

Oregon Health and Science University, Portland

Arizona Cancer Center, Tucson

Rush University Medical Center, Chicago

Dartmouth-Hitchcock Medical Center, Lebanon

Northern New Jersey Cancer Associates, Hackensack

BC Cancer Research Center, Vancouver

Queen Elisabeth II Health Sciences Center, Halifax

McGill University Department of Oncology, Montreal